SCHEMBL6166409

SCHEMBL6166409

Cc1nn(-c2ccc(Cl)nn2)c2c1C(=O)CCC2

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 7/20 0.56
CCNA2 P20248 1/20 0.53
CDK2 P24941 1/20 0.53
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HTT P42858 2/20 0.44
SLC34A1 Q06495 1/20 0.41
CYP1A2 P05177 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.37
OPRD1 P41143 2/20 0.37
OPRK1 P41145 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167013 0.85 CCNA2 (0.42) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6163291 0.85 CCNA2 (0.42) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166839 0.83 ALDH1A1 (0.50) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6165472 0.82 CCNA2 (0.42) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166942 0.82 HTT (0.43) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166582 0.81 OPRM1 (0.64) OPRM1CCNA2CDK2HTTKMT2A
SCHEMBL6166892 0.81 CCNA2 (0.53) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL6166211 0.78 CCNA2 (0.50) OPRM1CCNA2CDK2RAB9ASMN1; SMN2
SCHEMBL20074683 0.77 OPRM1 (0.55) OPRM1RAB9ASMN1; SMN2HTTSLC34A1
SCHEMBL6163994 0.77 HTT (0.39) OPRM1CCNA2CDK2RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed